5 Best Quality Stocks To Own For 2015

5 Best Quality Stocks To Own For 2015: IMAX Corp (IMAX)

IMAX Corporation, incorporated on January 1, 2002, together with its wholly owned subsidiaries, is an entertainment technology companies, specializing in motion picture technologies and presentations. The Companys customers who purchase lease or otherwise acquire the IMAX theatre systems are theatre exhibitors, which operate commercial theatres, museums, science centers, and destination entertainment sites. IMAX theatre systems combine the Companys digital re-mastering movie conversion technology (IMAX DMR), projectors with equipment and automated theatre control systems, sound system components, screens, theatre geometry, and theatre acoustics.

The Companys principal business is the design, manufacture and delivery of theater systems (IMAX theater systems). The Companys customers who purchase, lease or otherwise acquire the IMAX theater systems through joint revenue sharing arrangements are theater exhibitors that operate commercial theaters (part icularly multiplexes), museums, science centers, or destination entertainment sites. The Company does not own IMAX theaters, but licenses the use of its trademarks along with the sale, lease or contribution of the IMAX theater system.

IMAX Systems, Theater System Maintenance and Joint Revenue Sharing Arrangements

The Company provides IMAX theater systems to customers on a sales or long-term lease basis with an initial 10-year term. These agreements consist of initial fees and ongoing fees (which can include a fixed minimum amount per annum and contingent fees in excess of the minimum payments) and maintenance and extended warranty fees. The initial fees vary depending on the system configuration and location of the theater and generally are paid to the Company in installments between the time of system signing and the time of system installation. Ongoing fees are paid over the term of the contract, commencing after the theater system has been instal le! d and are generally equal to the greater of a fixed minimu! m amount per annum or a percentage of boxoffice receipts. The Company also provides IMAX theater systems to customers under joint revenue sharing arrangements, pursuant to which the Company provides the IMAX theater system in return for a portion of the customers IMAX box-office receipts, and in some cases concession revenues and/or a small upfront or initial payment. As at December 31, 2012, the Company had 316 theaters in operation under joint revenue sharing arrangements.

Production and Digital Re-Mastering (IMAX DMR)

The Companys technology digitally re-masters Hollywood films into IMAX digital cinema package format or 15/70-format film. IMAX DMR digitally enhances the image resolution of motion picture films for projection on IMAX screens while maintaining or enhancing the visual clarity and sound quality to levels for which The IMAX Experience is known. This technology enabled the IMAX theater network to release Hollywood films simultane ously with domestic release. In a typical IMAX DMR film arrangement, the Company will receive a percentage of net box-office receipts of any commercial films released in the IMAX network, which is generally 10-15%, from a film studio for the conversion of the film to the IMAX DMR format and access to its distribution platform. During the year ended December 31, 2012, 35 films converted through the IMAX DMR process were released to theaters within the IMAX network. As of December 31, 2012, the Company released 23 IMAX DMR titles to theaters within the IMAX network. During 2012, five local language IMAX DMR films were released, including one French film, Houba! On the Trail of the Marsupilami: The IMAX Experience and four Chinese IMAX DMR titles: Tai Chi 0: An IMAX 3D Experience, Tai Chi Hero: An IMAX 3D Experience, Back to 1942: The IMAX Experience and CZ12: The IMAX Experience.

Film Distribution and Post-Production

The Company is also a distributor o! f large-f! ormat films, primarily catering to its institution! al theate! r partners. The Company generally distributes films, which it produces or for which it has acquired distribution rights from independent producers. The Company generally receives a percentage of the theater box-office receipts as a distribution fee. Films produced by the Company are typically financed through third parties, whereby the Company will generally receive a film production fee in exchange for producing the film and a distribution fee for distributing the film. The Company utilizes third-party funding for the majority of original films it produces and distributes. In 2012, the Company, along with Warner Bros. Pictures (WB) and MacGillivray Freeman Films (MFF) released an original title, To the Artic 3D: An IMAX 3D Experience.

The Company derives a small portion of its revenues from other sources. As of December 31, 2012, the Company had four owned and operated theaters. In addition, the Company has a commercial arrangement with one theater resulting i n the sharing of profits and losses and provides management services to two theaters. The Company also rents its two dimensional (2D) and three dimensional (3D) large-format film and digital cameras to third party production companies. The Company maintains cameras and other film equipment and also offers production advice and technical assistance to both documentary and Hollywood filmmakers. Additionally, the Company generates revenues from the sale of after-market parts and 3D glasses. As of December 31, 2012, approximately 54.2% of IMAX systems in operation were located in the United States and Canada. As at December 31, 2012, approximately 45.8% of IMAX systems in operation were located within international markets (other than the United States and Canada).

Advisors' Opinion:

• [By Rick Munarriz]

  I went out on a limb last week, and now it's time to see how that decision played out.

  I predicted that IMAX (NYSE: IMAX  ) ! would clo! se higher on the week. With a strong slate of potential summer blockbusters hitting movie theaters these days, betting on the provider of super-sized multiplex experiences seemed like a good call during a week that has been historically busy at the box office. IMAX shares moved 1.2% higher on the week, pushing into positive territory with a strong Friday. I was right. I predicted that the tech-heavy Nasdaq would outperform the Dow Jones Industrial Average. (DJINDICES: ^DJI  ) . This has been a tricky call lately, so how did it play out this time? Well, the market closed nicely higher this week. The Nasdaq moved 2.2% higher, and the Dow managed to close just 1.5% higher. I was right. My final call was for Constellation Brands (NYSE: STZ  ) to beat Wall Street's income estimates in its latest quarter. The liquor leader behind Mondavi wines, Svedka vodkas, and other libations has been posting blowout quarterly results over the past year, and I was banking on seeing the trend continue. Analysts were looking for a profit of $0.40 a share during the quarter, but Constellation came through with adjusted net income of $0.38. I was wrong.

  Two out of three? I can do better than that.

• [By Rich Smith]

  On Monday, Mississauga, Ontario-based IMAX (NYSE: IMAX  ) announced that it has signed an agreement to install five IMAX theatres at existing Mexican multiplexes operated by Cinepolis. The agreement, once implemented, will give IMAX a total of 12 Cinepolis locations in Mexico, in addition to the one now operating in Brazil.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/5-best-quality-stocks-to-own-for-2015-2.html

Top Medical Companies To Buy Right Now

Top Medical Companies To Buy Right Now: Covidien PLC (COV)

Covidien Public Limited Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. It operates its businesses through three segments: Medical Devices, which includes the development, manufacture and sale of endomechanical instruments, energy devices, soft tissue repair products, vascular products, oximetry and monitoring products, airway and ventilation products; Pharmaceuticals, which includes the development, manufacture and distribution of specialty pharmaceuticals and active pharmaceutical ingredients, and Medical Supplies, SharpSafety products and original equipment manufacturer products. In May 2012, it acquired Newport Medical Instruments, Inc. In May 2012, it acquired superDimension, Ltd. In June 2012, the Company acquired Oridion Systems Ltd. In October 2012, its Mallinckrodt acquired CNS Therapeutics, Inc. In January 2013, the Company acquired CV Ingenuity. Advisors' Opinion:

• [By ovenerio]

  In this article, let's take a look at Covidien PLC. (COV), a $41.12 billion market cap company, that develops, makes and distributes medical devices and supplies and other health care products.

• [By Dan Carroll]

  Finally, Covidien (NYSE: COV  ) has also entered the renal denervation race, although this company looks to be behind St. Jude and Medtronic as the leaders. Covidien purchased small-time renal denervation player Maya Medical last year for up to $170 million including milestone payouts, and it also received European approval for its OneShot renal denervation system last year. However, Covidien only launched the OneShot commercially in January, putting it back with Boston Scientific in racing to catch up with St. Jude and Medtronic's advance.

• [By Keith Speights]

  Product recalls usually hurt companies. Covidien's (NYSE: COV  ) shares were temporarily affected by the company's ! recall of surgical tools last year. Johnson & Johnson stock took a hit in 2010 and early 2011 partially due to recalls of several products.

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/top-medical-companies-to-buy-right-now.html

Hot Forestry Companies To Own For 2015

Twitter tweeted September 12 that it had filed its S-1 registration statement with the SEC. The filing signals its intention to go public. Whatever its IPO price you know it's going to be extremely popular with institutions and big-time investors alike.

Saudi billionaire Prince Alwaleed bin Talal, who owns $300 million of its stock, expects Twitter�� IPO later this year or early in 2014. He believes Twitter won't make the same mistakes Facebook (Nasdaq:FB) did and will price its stock realistically. Ordinary investors, who will have a hard time laying their hands on some of its IPO shares, are faced with the difficult decision of whether to purchase its stock once Twitter opens for trading.

Rather than stress about this, I��e got three ways you can get in the back door.

Option One

If you're Michael Moe of San Francisco-based GSV Capital (Nasdaq:GSVC), this news is music to your ears. GSV owns 1.84 million common shares of the social media messaging service, which it paid $33 million for ($18 per share) over a 12-month period between Q3 2011 and the Q2 2012. Recently these shares have traded between $20 and $30 on the secondary market. At the high-end, GSV is sitting on a $22 million unrealized gain. Twitter, which represents 15% of its overall investment portfolio, is far more important to the company than Facebook was when it went public in May 2012, and that debacle cut GSV's market cap by more than half in little more than two months. Any hiccup in Twitter's IPO could drop GSV's stock to single digits.

Hot Forestry Companies To Own For 2015: Supernus Pharmaceuticals Inc (SUPN)

Supernus Pharmaceuticals, Inc. (Supernus), incorporated on March 30, 2005, is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Supernus is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder (ADHD). Supernus�� two epilepsy product candidates are SPN-538 and Epliga. Epliga is in Phase III clinical trials. Supernus ADHD product candidates include SPN-810 (molindone hydrochloride), a treatment for impulsive aggression in patients with ADHD, and SPN-812, a non-stimulant treatment for ADHD. Both of these programs are in Phase II. In addition to these four products candidates, Supernus has several additional product candidates in various stages of development, including SPN-809. Its wholly owned subsidiary includes TCD Royalty Sub LLC.

Supernus�� Late-Stage Neurology Portfolio

SPN-538 is an oral once-daily extended release topiramate product for the treatment of epilepsy. Topiramate is marketed by Johnson & Johnson under the brand name Topamax and is available in a generic form. As of December 31, 2009, Topiramate was available only in immediate release form and is indicated for monotherapy and adjunctive therapy of epilepsy and for the treatment of migraine. It works by enhancing the inhibitory effect of the Gamma-Aminobutyric Acid (GABA) neurotransmitter that regulates neuronal excitability throughout the nervous system, blocking the excitatory effect of the glutamate neurotransmitter, blocking the sodium channel and inhibiting the carbonic anhydrase enzyme.

Epliga is an oral once-daily extended release formulation of oxcarbazepine. As of December 31, 2009, Epliga was in Phase III trials. Oxcarbazepine is marketed by Novartis under the brand name Trileptal and is available in a generic form. Trileptal is indicated for monotherap! y and adjunctive therapy of epilepsy. Oxcarbazepine is an active voltage-dependent sodium channel blocker.

Supernus�� Psychiatry Portfolio

SPN-810 (molindone hydrochloride) is a treatment for impulsive aggression in patients with ADHD. As of December 31, 2009, it was in Phase II. SPN-810 is based on molindone hydrochloride. As of December 31, 2009, the Company had completed four clinical trials for SPN-810, including a Phase IIa trial, in which it tested the safety and tolerability of immediate release molindone hydrochloride in children with ADHD who suffer from serious persistent conduct problems. This open-label, dose-ranging trial randomized 78 children, 6-12 years of age, into one of four treatment groups, which were given four different doses of immediate release molindone hydrochloride, between 10 milligram and 40 milligram per day, depending on weight, three times a day over a six-week treatment period, after 2-5 weeks of titration. SPN-810 was well tolerated in the trial with no clinically meaningful changes in standard hematology, clinical chemistry values, vital signs or electrocardiogram results. SPN-810 also showed improvements on the primary and secondary outcome measures, such as conduct problem and ADHD scales, across all four treatment groups. SPN-812 is a non-stimulant treatment for ADHD. As of December 31, 2009, SPN-812 was in Phase II. SPN-812 is a selective norepinephrine reuptake inhibitor.

Supernus�� Technology Platforms

The Company has a long track record of developing products by applying technologies to known drugs to improve existing therapies and to enable the treatment of new indications. Supernus�� main technology platforms include: Microtrol (multiparticulate delivery platform), Solutrol (matrix delivery platform) and EnSoTrol (osmotic delivery system). The Company�� technologies have been used in the approved and marketed products, including Carbatrol (carbamazepine), Equetro (carbamazepine), Adderall XR (mixe! d ampheta! mine salts), Sanctura XR (trospium chloride), Oracea (doxycycline) and Intuniv (guanfacine).

Advisors' Opinion:

• [By Monica Gerson]

  Supernus Pharmaceuticals (NASDAQ: SUPN) is expected to post a Q4 loss at $0.55 per share on revenue of $7.78 million.

  Geron (NASDAQ: GERN) is projected to post a Q4 loss at $0.07 per share on revenue of $350.00 thousand.

Hot Forestry Companies To Own For 2015: Soditech Ingenierie SA (SEC)

Soditech Ingenierie SA is a France-based company that is primarily engaged in electronic and mechanical engineering services in various sectors. The Company�� activity is organized into three sectors: Defense & Research, Space and Energy & Nuclear. It provides specialized services in four fields: aerospace, covering communication satellites, observation satellites and space stations; automotive, providing such services as engine design and plasturgy for equipment manufacturers; aeronautics, offering structural research for aircraft makers, instruments or electro-mechanical systems for assisting pilots and others, and defense, providing engineering of numerous tests and trials systems, with or without implementations, among others. The Company also offers additional services, such as energy forecasting and environmental analysis, environmental management system, and others. In May 2014, it restructured company into three main divisions: Defense & Research, Space and Energy & Nuclear. Advisors' Opinion:

• [By Damian Illia]

  Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings filed by institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission (SEC). In this article, let's concentrate on one particular hedge fund and try to see the principal holdings in its portfolio. I will look into Renaissance Technologies LLC from Jim Simons (Trades, Portfolio), a private investment firm based in New York.

• [By Victor Selva]

  Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings by filed institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission (SEC). In this article, let's concentrate in one particular hedge fund and try to see the principal holdings in its portfolio. I will look into Tudor Investment Corp in which Paul Tudor Jones (Trades, Portfolio) serve as chief investment officer.

• [By ovenerio]

  Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings by filed institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission (SEC). In this article, let麓s concentrate in one particular hedge fund and try to see the principal holdings in its portfolio. I will look into America First Investment Advisor.Recently the fund reported its equity portfolio, as at the end of June. The total value of the portfolio amounted to $222.9 million, up from $203.2 million disclosed at the end of the previous quarter. Consequently, the fund's total return was 9.7% in the last quarter. The filing revealed that at the end of June, the fund added 14 new positions to its equity portfolio, and sold out of 24 other companies. The top ten portfolio holdings as of the end of the quarter represented 41.8%. The largest changes from previous 13-F麓s fillings are in the tech and energy sectors.In this article, we have selected three companies, in which the fund holds the largest stakes, in terms of market value.The first on the list is The Clorox Company (CLX), in which the fund disclosed a $10.53 million stake with over 115,150 shares. The company is a diversified producer of household cleaning, grocery and specialty food products is also a leading producer of natural personal care products.Long-Term VisionIn October 2013, Clorox introduced its 2020 Strategy. The 2020 Strategy focuses on delivering long-term, profitable growth through the year 2020. The key elements of its strategy to grow sales and earnings over the long term are: category, channel and geographic expansion, increased brand investment, and cost reductions.The company's long-term financial goals include:Growing net sales 3-5 percent annuallyExpanding EBIT margin 25-50 basis points annuallyGenerating free cash flow of 10% to 12% of sales annuallyIt has improved earnings

• [By Patricio Kehoe]

  Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings filed by institutional investment managers with at least $100 million in equity assets under management, as required by the U.S. Securities and Exchange Commission (SEC). In this article, let麓s concentrate in one particular hedge fund and try to see the principal holdings in its portfolio. I will look into Citadel Advisor LLC from Kenneth C. Griffin, a Chicago-based investment firm.

Top 10 Chemical Stocks To Invest In Right Now: Imperva Inc (IMPV)

Imperva, Inc. (Imperva), incorporated on April 2002, is engaged in providing data security solutions focused on providing visibility and control over business data across systems within the data center. The Company�� securesphere data security suite is a solution designed to prioritize and mitigate risks to high-value business data, protect against hackers and malicious insiders and address and streamline regulatory compliance. SecureSphere is an integrated, modular suite, which provides database, file and Web application security and secures all business data across a range of systems in data centers, including traditional on-premise data centers as well as private, public and hybrid cloud computing environments. The Company also offers on-demand, cloud-based security services. The Company has two segments: Imperva, which is comprised of its financial position and results of operations and those of the Company�� wholly owned subsidiaries, and Incapsula, which is comprised of the financial position and results of operations of the Company�� majority owned subsidiary. In February 2014, Imperva Inc acquired real-time mainframe security auditing agents from Tomium Software.

The Company�� products include SecureSphere data security suite for enterprise data centers and its cloud-based security services that it provides through Incapsula for mid-market enterprises and small and medium business (SMBs). The Company�� solution includes database security, file security and Web application security.

Database Security

Database security provides full visibility and control over structured business data repositories, including database data usage, vulnerabilities and access rights and enables security, audit, risk and information technology (IT) professionals to improve data security and address compliance requirements. The database products cover the enterprise database platforms, including Oracle, MS-SQL, IBM DB2, Sybase, Informix, MySQL, Progress, Teradata and ! Netezza. The database security products include discovery and assessment server, database activity monitoring, database firewall, user rights management for databases and analog-to-digital converter (ADC) insights. The discovery and assessment server automates the process of discovering databases and other business data on the network and performs a security assessment to identify risks to high-value business data. Database activity monitoring includes all discovery and assessment server functionality. Database firewall includes database activity monitoring functionality. User rights management for databases enables the management of user rights across heterogeneous enterprise databases by aggregating user rights to illustrate what rights users have to business data. ADC Insights provides user tracking for identifying the real end user behind database transactions.

The Company competes with International Business Machines Corporation, McAfee, Inc. and Oracle Corporation.

File Security

File security provides full visibility and control over unstructured business data repositories, including file ownership, usage and access rights and enables security, audit, risk and information technology (IT) professionals to improve file data security and address compliance requirements. The file security products are designed to secure files, including spreadsheets, presentation slides, word processing documents and portable document format (PDFs) containing high-value business data that its customers store in unstructured repositories, such as file servers, network attached storage and storage area network devices. The File security products include user rights management for files, file activity monitoring and file firewall. User rights management for files enables the management of user access rights across multiple different file storage systems by aggregating user rights based on organizational context and actual file usage to illustrate what rights users have to sensitive ! files. Fi! le activity monitoring includes all user rights management for files functionality. File firewall includes all file activity monitoring functionality, and provides real-time blocking of suspicious activity that violates corporate policies.

The Company competes with EMC Corporation and Symantec Corporation.

Web Application Security

Web application security protects Web applications from large scale cyber attacks, adapts to evolving threats to prevent data breaches and addresses compliance requirements. Its product includes Web application firewall (WAF), which fortifies Web defenses with research-driven intelligence on current threats.

The Company competes with Citrix Systems, Inc. and F5 Networks, Inc.

Cloud-Based Services

The Company�� cloud-based service offerings are its Incapsula service, the Imperva Cloud WAF Service and its ThreatRadar subscription service. The Incapsula service is designed to be easy to deploy and to be accessible to small and medium size businesses that need data security and compliance solutions, but do not have the size or resources to deploy its SecureSphere WAF appliances into their own Website infrastructure. Incapsula�� security and optimization offerings include the services, including Web application firewall services, content delivery optimization and distributed denial of service-attack prevention. Web application firewall services provide enterprise-grade blocking of attacks against Web applications to help ensure Website safety and availability; enhanced security through real-time and centralized threat detection across all protected Websites; allows customers to address compliance requirements. Content delivery optimization optimizes Website performance by reducing page load times, server load and bandwidth consumption. Distributed denial of service-attack prevention blocks malicious attack traffic and allows filtered, legitimate traffic to flow to the customer Website allowing its b! usiness t! o run without interruption.

Imperva Cloud WAF powered by Incapsula, bundles the incapsula service with managed support services from our security operations center (SOC). Managed services include provisioning, security alert notifications and tuning, incident response, real time service dashboard and statistics, customer support and weekly reports on alerts and attack trends. ThreatRadar is an add-on, premium subscription service for the Company�� SecureSphere WAF appliance that recognizes attack sources and dynamically adjusts Web security policies within its SecureSphere WAF appliance to provide protection against them.

The customers include four of the telecommunications companies, three of the commercial banks in the United States, three of the financial data service firms, three of the computer hardware companies, two of the food and drug store companies, over 150 government agencies worldwide and more than 100 Fortune 1000 companies. The Company primarily sells its products and services through its network of over 350 channel partners worldwide, including both distributors and resellers. The Company derives its revenue from sales and licenses of its products and sales of its services. Services revenue consists of maintenance and support, professional services and training and subscriptions. A majority of the Company�� revenue is derived from customers in the Americas region. As of December 31, 2010, 66% of its total revenue was generated from the Americas, 24% from Europe, Middle East and Africa (EMEA) and 10% from Asia Pacific, and for the six months ended June 30, 2011, 63% of its total revenue was generated from the Americas, 24% from EMEA and 13% from Asia Pacific.

Advisors' Opinion:

• [By Monica Gerson]

  Imperva (NYSE: IMPV) shares tumbled 37.68% to $30.99 after the company cut its first-quarter outlook. Imperva now expected a loss of $0.40 to $0.44 per share, on revenue of $31 million to $31.5 million.

• [By Garrett Cook]

  Technology shares jumped by 1.69 percent in today’s trading. Top gainers in the sector included Imperva (NYSE: IMPV), up 21.6 percent, and Spansion (NYSE: CODE), up 20 percent.

Hot Forestry Companies To Own For 2015: KB Home (KBH)

KB Home is a homebuilding company. The Company constructs and sells homes through its operating divisions under the name KB Home. The Company operates in nine states and 32 markets, including California, Arizona, Nevada, Colorado, Texas, Florida, Maryland, North Carolina and Virginia. The Company organizes its homebuilding operations into four segments: West Coast, Southwest, Central and Southeast. In July 2012, it acquired land within the Elworthy Ranch property in the town of Danville. In September 2012, it acquired Mason Ranch, which is a 330-acre land asset in Cedar Park/Leander West, submarkets in metropolitan Austin. In December 2012, the Company acquired 65 lots in Fuquay-Varina, N.C.

Homebuilding

The Company�� homebuilding operations offers a variety of homes designed primarily for first-time, move-up and active adult homebuyers, including attached and detached single-family homes, townhomes and condominiums. It offers homes in development communities, at urban in-fill locations and as part of mixed-use projects. During the fiscal year ended, November 30, 2011 (fiscal 2011), the Company, through its homebuilding segment, delivered 5,812 homes. During fiscal 2011, homebuilding operations accounted for 99.2% of the total revenues.

Financial Services

The financial services segment provides title and insurance services to its homebuyers. This segment also provided mortgage banking services to the Company�� homebuyers indirectly through KBA Mortgage, LLC (KBA Mortgage), a former unconsolidated joint venture of a subsidiary of ours and a subsidiary of Bank of America, N.A., from the venture�� formation until June 30, 2011, when it ceased offering mortgage banking services. Effective June 27, 2011, it entered into a marketing services agreement with MetLife Home Loans, a division of MetLife Bank, N.A. Under the agreement, MetLife Home Loans��personnel, located on site at several of its new home communities, can offer financing options and re! sidential consumer mortgage loan products to its homebuyers, and originate residential consumer mortgage loans for homebuyers who elect to use MetLife Home Loans. The Company�� homebuyers may also elect to use other providers of mortgage banking services. Its financial services operations accounted for 0.8% of the Company�� total revenues in fiscal 2011.

Advisors' Opinion:

• [By shash63]

  KB Home (KBH) has been acquiring land in San Antonio over the last few years. Last year, it acquired approximately 200 acres of land in this market. It will build a community named CrossCreek in San Antonio comprising of 600 homes. This community will open in two phases, with first phase started in the end of 2013 and the second phase in 2014. The company will offer 12 different home designs. This vast variety of designs will boost demand, which will increase the company's home revenue. Total revenues grew 11% to $450.7 million from $405.2 million in the year-earlier quarter, primarily on higher housing revenues.

• [By Anora Mahmudova]

  Shares in KB Home (KBH) �jumped 5.9% after the home maker swung to profit in its fiscal first quarter, beating analysts estimates.

Hot Forestry Companies To Own For 2015: Lance Inc.(LNCE)

Snyder?s-Lance, Inc. manufactures, markets, and distributes snack food products primarily in the United States. Its products include pretzels, sandwich crackers, kettle chips, cookies, potato chips, tortilla chips, other salty snacks, sugar wafers, nuts, and restaurant style crackers. The company sells its products principally under the Snyder?s of Hanover, Lance, Cape Cod, Krunchers!, Jays, Tom?s, Archway, Grande, Stella D?oro, O-Ke-Doke, EatSmart, and Padrinos brand names. It also purchases and sells cakes, meat snacks, and candy under its brands, as well as partner brand products for resale. Snyder?s-Lance, Inc. sells its products through direct-store-delivery network, distributors, and direct sales to grocery/mass merchandisers, convenience stores, club stores, discount stores, food service establishments, drug stores, schools, military and government facilities, recreational facilities, offices, and other independent retailers. The company was formerly known as L ance, Inc. and changed its name to Snyder?s-Lance, Inc. in December 2010. Snyder?s-Lance, Inc. was founded in 1912 and is headquartered in Charlotte, North Carolina with additional offices in Hanover, Pennsylvania.

Advisors' Opinion:

• [By Alex Planes]

  At a quarter the size of Snyder's-Lance (NASDAQ: LNCE  ) , Diamond could actually be a buyout candidate in its own right, assuming its larger competitors can come to trust its accounting. It would be an easy acquisition for either Kellogg or General Mills� (NYSE: GIS  ) , neither of which has any notable nut or popcorn brands to speak of.

• [By Rich Duprey]

  As part of snack food maker�Snyder's-Lance's� (NASDAQ: LNCE  ) first-quarter earnings report today,�it�announced the payment�of its regularly quarterly dividend of $0.16 per share.

Top Airline Stocks To Own For 2015

Before Monday’s opening bell, aerospace company Boeing Co (BA) announced that it has received a $6 billion order for 60 of its 737 aircraft.�

This order includes Next-Generation 737 and 737 MAX airplanes. In total, the agreement is worth approximately $6 billion.

Ihssane Mounir, vice president of Boeing’s Sales and Marketing, Northeast Asia commented: “Our long-standing and productive partnership with Air China dates back to the airline’s beginning and we are proud the 737 has been part of their success. We are excited to see that the 737 family will play a significant role in Air China’s continued success.”

BA Dividend Snapshot

As of Market Close on December 19, 2014

Top Airline Stocks To Own For 2015: WestJet Airlines Ltd (WJA)

WestJet Airlines Ltd. (WestJet) provides airline service and travel packages with scheduled service to more than 85 destinations in North America, Central America and the Caribbean, and has partnership agreements with over 30 airlines around the world. WestJet operates a fleet of more than 100 Boeing Next-Generation 737 and Bombardier Q400 NextGen aircraft. The Company�� subsidiaries include WestJet Investment Corp., WestJet Operations Corp., WestJet Vacations Inc. and WestJet Encore Ltd. Advisors' Opinion:

• [By Gerrit De Vynck]

  Closely held Porter unveiled plans in April to add as many as 30 CSeries jets in an order valued at as much as $2.1 billion from Montreal-based Bombardier to reach as far as Los Angeles and the Caribbean as it challenges the country�� two biggest carriers, Air Canada and WestJet Airlines Ltd. (WJA) The order, which would be Bombardier�� first for the aircraft with a Canadian carrier, is conditional on the runway extension and a removal of the jet ban.

• [By Eric Lam]

  BlackBerry, the smartphone maker looking to sell itself, lost 3.6 percent to pace declines among technology stocks. WestJet (WJA) Airlines Ltd. dropped 2.5 percent as load factor slipped in September. Valeant Pharmaceuticals International Inc. rose 1.4 percent after receiving approvals for products in the U.S. and Canada. Agrium Inc. added 0.7 percent after naming a successor for its retiring chief executive officer.

Top Airline Stocks To Own For 2015: Allegiant Travel Co (ALGT)

Allegiant Travel Company, incorporated on April 4, 2006, is a leisure travel company focused on providing travel services and products to residents of small, underserved cities in the United States. The Company operates a passenger airline marketed primarily to leisure travelers in small cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third party services and products. In addition, it provides air transportation under fixed fee flying arrangements. The Company provides scheduled air transportation on limited frequency nonstop flights between small city markets and leisure destinations. As of February 1, 2013, its operating fleet consisted of 58 MD-80 aircraft and six Boeing 757-200 aircraft providing service on 191 routes to 85 cities including 13 leisure destinations and 72 small cities and including cities served seasonally. In January 2012, the Company took ownership of two MD-80 aircraft. In October 2012, the Company announced the formation of Allegiant Systems, a joint venture with AvIntel and Lixar IT.

The Company provides unbundled air-related services and products in conjunction with air transportation for an additional cost to customers. These optional air-related services and products include use of its Website for purchases, use of its call center for purchases, advance seat assignment, baggage fees, priority boarding, its own travel protection product, change fees, food and beverage purchases on board and other air-related services. The Company offers third party travel products, such as hotel rooms, ground transportation (rental cars and hotel shuttle products) and attractions (show tickets) bundled with the purchase of its air transportation.

The Company provides air transportation through fixed fee agreements and charter service on a seasonal and ad-hoc basis for other customers. As of February 1, 2013, its operating aircraft consisted of 58 MD-80 aircraft and six Boeing 757-200 aircraft. D! uring the year ended December 31, 2012, the Company has entered into purchase agreements to acquire seven Airbus A320 aircraft and operating lease agreements for an additional nine Airbus A319 aircraft.

The Company competes with AirTran, Frontier, Spirit, Southwest, US Airways, Alaska Airlines, Horizon Air, Delta, Xtra, United and American.

Advisors' Opinion:

• [By Ben Levisohn]

  DeNardi also rates Alaska Air (ALK), Spirit Airlines (SAVE) and Allegiant Travel (ALGT) as Buys and Southwest, JetBlue Airways (JBLU) and Hawaiian Holdings (HA) as holds.

• [By Alex Planes]

  It's been a bit over two months since my fellow Fool Sean Williams pointed out that Republic, despite its low price, was booking fewer passenger-miles in 2013 and could be set for a fall. Since then, Republic's shares have shed approximately 15% of their value. To counter the possibility of revenue declines, the airline joined Spirit Airlines (NASDAQ: SAVE  ) and Allegiant Travel (NASDAQ: ALGT  ) last month in charging a fee for carry-on baggage, which is more or less the final frontier of irritating airline charges, short of charging you for the oxygen should those masks drop down during an emergency.

Top 5 Supermarket Stocks To Invest In Right Now: Ryanair Holdings PLC (RYA)

Ryanair Holdings plc (Ryanair Holdings), is a holding company for Ryanair Limited (Ryanair). Ryanair operates a low-cost, scheduled-passenger airline serving short-haul, point-to-point routes between Ireland, the United Kingdom, Continental Europe, and Morocco. As of June 30, 2012, the Company offered approximately over 1,500 scheduled short-haul flights per day serving approximately 160 airports largely throughout Europe with an operating fleet of 294 aircraft flying approximately 1,500 routes. Ryanair sells seats on a one-way basis. The Company also holds a 29.8% interest in Aer Lingus Group plc. As of June 30, 2012, Ryanair�� operating fleet was composed of 294 Boeing 737-800 aircraft, each having 189 seats. Ryanair�� fleet totaled 294 Boeing 737-800s at March 31, 2012. As of June 30, 2012, Ryanair owned and operated four Boeing 737-800 full flight simulators for pilot training. Advisors' Opinion:

• [By Inyoung Hwang]

  Ryanair Holdings Plc (RYA), the discount airline operator that�� the second-biggest stock in Ireland�� ISEQ index, declined 1.7 percent to 7.23 euros in Dublin. Kerry Group, a supplier of food ingredients, sank 1.4 percent to 45.24 euros.

Top Airline Stocks To Own For 2015: Alaska Air Group Inc. (ALK)

Alaska Air Group, Inc., through its subsidiaries, Alaska Airlines, Inc. and Horizon Air Industries, Inc., operates as an airline company serving destinations in the western United States, Canada, and Mexico. The company provides passenger air services; and freight and mail services primarily to and within the state of Alaska and on the West Coast. As of December 31, 2009, it operated a fleet of 110 jet aircraft; and Horizon Air Industries operated a fleet of 18 jets and 40 turboprop aircraft. The company was founded in 1932 and is based in Seattle, Washington.

Advisors' Opinion:

• [By Tim Beyers]

  Who wins? We won't know for years, but Southwest is already the leading buyer of the MAX, and as such, seems to be a likely benefactor. There's also Alaska Airlines (NYSE: ALK  ) , which already flies from the continental west coast to various destinations in the Hawaiian Islands. The airline has ordered 37 of the planes to upgrade its fleet.

• [By Stephen Quickel]

  Seattle-based Alaska Air Group (ALK), under attack by Delta Air Lines on its home turf, has been expanding southward into Salt Lake City, New Orleans, and Tampa.

Top Airline Stocks To Own For 2015: Latam Airlines Group SA (LFL)

LAN Airlines S.A. (LAN), incorporated in 1983, is the international and domestic passenger airline in Latin America and the cargo operator in the region. As of February 9, 2012, LAN and its affiliates provided domestic and international passenger services in Chile, Peru, Ecuador, Argentina and Colombia and cargo operations through the use of belly space on its passenger flights and cargo freighter aircraft through its cargo airlines in Chile, Brazil, Colombia and Mexico. LAN and its affiliates offered passenger flights to 15 destinations in Chile, 59 destinations in other South American countries, 15 destinations in other Latin American countries and the Caribbean, five destinations in the United States, two destinations in Europe and four destinations in the South Pacific and, through various codeshare agreements, service to 25 additional destinations in North America, 16 additional destinations in Europe, 27 additional destinations in Latin America and the Caribbean (including Mexico), and two destinations in Asia, as of February 9, 2012. LAN and its affiliates provide cargo service to all of their passenger destinations and to 20 additional destinations served only by freighter aircraft. LAN also offers other services, such as ground handling, courier, logistics and maintenance. LAN and its affiliates operated a fleet, with 135 passenger aircraft and 14 cargo aircraft as of December 31, 2011. On February 15, 2011, Lan Pax Group S.A., subsidiary of Lan Airlines S.A. acquired 100% of Colombian society AEROASIS S.A.

LAN is primarily involved in the transportation of passengers and cargo. Its operations are carried out principally by Lan Airlines and also by a number of different subsidiaries. As of February 28, 2011, in the passenger business the Company operated through six main airlines: Lan Airlines, Transporte Aereo S.A. (which does business under the name Lan Express), Lan Peru S.A. (Lan Peru), Aerolane Lineas Aereas Nacionales del Ecuador S.A. (Lan Ecuador), Lan Argentina S.A. (Lan ! Argentina, previously Aero 2000 S.A.) and the Aerovias de Integracion Regional, Aires S.A. (Aires). As of February 28, 2011, the Company held a 99.9% interest in Lan Express through direct and indirect interests, a 70.0% interest in Lan Peru through direct and indirect interests, a 71.9% indirect interest in Lan Ecuador, a 99.0% indirect interest in Lan Argentina and a 94.99% indirect interest in Aires (a Colombian entity which was acquired on November 26, 2010). Its cargo operations are carried out by a number of companies, including Lan Airlines and Lan Cargo. As of February 28, 2011, the Company held a 69.2% interest in Aero Transportes Mas de Carga S.A. de C.V. (MasAir), through direct and indirect participations, a 73.3% interest in ABSA through direct and indirect participations, and a 90.0% interest in LANCO through direct and indirect participations. In the cargo business, the Company markets itself primarily under the Lan Cargo brand. In addition to its air transportation activities, the Company provides a series of ancillary services. It offers handling services, courier services and logistics, small package and express door-to-door services through Lan Airlines and various subsidiaries.

Passenger Operations

As of February 28, 2011, the Company operated passenger airlines in Chile, Peru, Ecuador, Argentina and Colombia. As of February 28, 2011, our passenger operations were performed through airlines in Chile, Peru, Ecuador, Argentina and Colombia where we operate both domestic and international services. As of February 28, 2011, the Company�� network consisted of 15 destinations in Chile, 14 destinations in Peru, four destinations in Ecuador, 14 destinations in Argentina, 24 destinations in Colombia, 14 destinations in other Latin American countries and the Caribbean, five destinations in the United States, one destination in Canada, three destinations in Europe and four destinations in the South Pacific. Within Latin America, it has routes to and from Argentina, B! olivia, B! razil, Chile, Colombia, Cuba, the Dominican Republic, Ecuador, Mexico, Peru, Uruguay and Venezuela. The Company also flies to a variety of international destinations outside Latin America, including Auckland, Fort Lauderdale, Frankfurt, Los Angeles, Madrid, Miami, Mount Pleasant (Falkland Islands), New York, Toronto, Papeete (Tahiti), Paris, San Francisco, and Sydney. In addition, as of February 28, 2011, through its various code-share agreements, the Company offered service to 25 additional destinations in North America, 16 additional destinations in Europe, 25 additional destinations in Latin America and the Caribbean (including Mexico), and two destinations in Asia. As of February 28, 2011, the Company operated scheduled international services from Chile, Peru, Ecuador and Argentina through Lan Airlines; Lan Express in Chile; Lan Peru in Peru; Lan Ecuador in Ecuador; Lan Argentina in Argentina and Aires in Colombia. Its international network combines the Company�� Chilean, Peruvian, Ecuadorian, Argentinean and Colombian affiliates. It provides long-haul services out of its four main hubs in Santiago, Lima, Guayaquil and Buenos Aires. It also provides regional services from Chile, Peru, Ecuador and Argentina.

Cargo Operations

The Company�� cargo business operates on the same network used by the passenger airlines business, which is supplemented by freighter-only operations. The Company carries cargo for a variety of customers, including other international air carriers, freight-forwarding companies, export oriented companies and individual consumers. As of February 28, 2011, the Company operated a fleet of 140 aircraft, comprised of 126 passenger aircraft and 14 cargo aircraft.

The Company competes with UPS, FedEx, Centurion, Transportes Aereos Mercantiles Panamericanos S.A., Polar Air, Cargolux, Lufthansa Cargo, Martinair and Air France-KLM.

Advisors' Opinion:

• [By Laura Brodbeck]

  Notable earnings releases expected on Monday include:

  LAN Chile S.A. (NYSE: LFL) is expected to report fourth quarter EPS of $0.24 on revenue of $3.50 billion, compared to last year�� EPS of $0.02 on revenue of $3.48 billion. JA Solar Holdings, Co. Ltd (NASDAQ: JASO) is expected to report EPS of $0.03 on revenue of $291.75 million, compared to last year�� loss of $2.65 per share on revenue of $268.09 million. Sterling Construction Company, Inc�(NASDAQ: STRL) is expected to report a fourth quarter loss of $1.47 per share on revenue of $153.07 million, compared to last year�� EPS of $0.18 on revenue of $158.09 million.

  Economics

• [By Monica Gerson]

  LATAM Airlines Group SA (NYSE: LFL) is expected to post its Q1 earnings at $0.20 per share on revenue of $3.42 billion.

  Gladstone Investment (NASDAQ: GAIN) is projected to post its Q4 earnings at $0.17 per share on revenue of $8.90 million.

Top Airline Stocks To Own For 2015: JetBlue Airways Corporation(JBLU)

JetBlue Airways Corporation provides passenger air transportation services in the United States. As of December 31, 2011, it operated approximately 700 daily flights to 70 destinations in 22 states, Puerto Rico, and Mexico; and 12 countries in the Caribbean and Latin America through a fleet of 120 Airbus A320 aircraft and 49 EMBRAER 190 aircraft. The company, through its subsidiary, LiveTV, LLC, provides in-flight entertainment, voice communication, and data connectivity systems and services for commercial and general aviation aircraft, including live in-seat satellite television, digital satellite radio, wireless aircraft data link service, and cabin surveillance systems. JetBlue Airways Corporation was founded in 1998 and is based in Forest Hills, New York.

Advisors' Opinion:

• [By WWW.DAILYFINANCE.COM]

  Getty Images @Lebeaucarnews Here's something those trying to cash in on frequent flyer miles or points seldom hear: It's now easier to book the flight you want to the destination you want. The annual Switchfly Reward Seat Availability Survey, which gauges the frequent flyer programs at 25 of the world's largest airlines, found seats were available for frequent flyer redemption on 72.4 percent of the flights checked. That's a 1.3 percent increase compared with the prior year. "I was surprised by this year's results," said Jay Sorensen, president of IdeaWorks consulting firm, which surveyed 7,640 flights in March. "Typically, when you see the industry recovering from financial duress, one of the things they cut back on is giving away free seats." Instead, many airlines have actually made frequent flyer seats available on more of their flights. Sorensen credits the boost to the independent credit cards many flyers now use to rack up award miles that they can redeem without restrictions. Those credit cards, like the one offered by Capitol One, have become popular with consumers, and have forced airlines to make it easier for members of their own frequent flyer programs to cash in miles or points in order to compete. "[The airlines] want to compete against the bank-issued credit cards, so this is one way for them to do that," Sorensen said. Another factor is an accounting rule that says airlines can book revenue from the sale of frequent flyer miles only after the passenger has traveled. Low-cost carriers offer the most options As has been the case in past years, low-cost carriers have the most flights offering seats for frequent flyer redemption, according to the study. On average, 95.8 percent of the low-cost airline flights surveyed had seats available. By comparison, traditional airlines had frequent flyer award seats on 65 percent of their flights. That's up 4 percent from last year, but still well below the availability offered by low-cost airlin

• [By Ben Levisohn]

  Back on July 8, Morgan Stanley’s John Godyn predicted that United Continental (UAL) would execute a turnaround before JetBlue (JBLU). If today’s earnings are anything to go by, that appears to be a good call.

Top Airline Stocks To Own For 2015: Grupo Aeromexico SAB de CV (AEROMEX*)

Grupo Aeromexico SAB de CV is a Mexican holding company primarily engaged in the provision of passenger and cargo air transport services. It offers destinations in Mexico, the United States, Europe, Central and South America, Asia and Canada. It operates a fleet of over 110 aircrafts. The Company is primarily engaged in the passenger transportation segment, comprising regional, domestic and international routes, and package holidays; as well as in cargo transportation segment, handled mainly by its subsidiary Aeromexico Cargo. By its subsidiaries the Company is also engaged in real estate sector and in providing services to the aviation companies, including personnel training, management, and aircraft maintenance and modification. Its subsidiaries include Aerovias de Mexico SA de CV, Premier Loyalty & Marketing SAPI de CV, and Inmobiliaria Avenida Fuerza Aerea Mexicana 416 SA de CV, among others. In addition, it is a member of the SkyTeam airline alliance. Advisors' Opinion:

• [By Jonathan Levin]

  Volaris became Mexico�� second publicly traded carrier, after larger competitor Grupo Aeromexico SAB (AEROMEX*) sold stock in 2011. Airlines in Mexico have expanded into a void left when Cia. Mexicana de Aviacion, then largest based on passenger traffic, sought protection from creditors and ceased operations in 2010.

Top Airline Stocks To Own For 2015: China Eastern Airlines Corp Ltd (CEA)

China Eastern Airlines Corporation Limited (China Eastern), incorporated on April 14, 1985, is an air carriers operating in the People�� Republic of China. As of December 31, 2010, the Company served a route network that covers 182 domestic and foreign cities in 30 countries. It operates from Shanghai�� Hongqiao International Airport and Pudong International Airport. During the year ended December 31, 2010, its flights accounted for 52.2% and 37.9% of all the flight traffic at Hongqiao International Airport and Pudong International Airport, respectively. During 2010, it accounted for approximately 31.1% of the total passenger traffic volume and 19% of the total freight volume on routes to and from Shanghai. As of December 31, 2010, it had a fleet of 355 aircraft, including 337 passenger jets each with a seating capacity of over 100 seats and 18 freighters.

Passenger Operations

During 2010, the Company operated approximately 9,600 scheduled flights per week, excluding charter flights, serving a route network that covers 182 domestic and foreign cities in 30 countries. During 2010, its domestic routes generated approximately 71.5% of its passenger revenues. Its heavily traveled domestic routes link Shanghai to the commercial and business centers of the People�� Republic of China, such as Beijing, Guangzhou and Shenzhen. During 2010, it also operated approximately 361 flights per week to and from Hong Kong, originating from Shanghai and 16 major cities in eastern, northern and western the People�� Republic of China. During 2010, it operated approximately 103 flights per week between mainland China and Taiwan. During 2010, its regional routes accounted for approximately 5.4% of its passenger revenues. During 2010, it operated approximately 1,079 international flights per week, serving 60 cities in 29 countries, linking Shanghai to cities in Asian and Southeast Asian countries, such as Japan, Korea, India, Singapore, Thailand and Bangladesh and locations in Europe, the Un! ited States and Australia.

During 2010, the Company re-started its Shanghai to London and Shanghai to Moscow routes. During 2010, revenues derived from its operations on international routes accounted for approximately 23.2% of its passenger revenues. During 2010, revenues derived from its operations to and from Japan accounted for approximately 7.7% of its passenger revenues and approximately 33.4% of its international passenger revenues. Its international and regional flights and a portion of its domestic flights either originate or terminate in Shanghai, the central hub of its route network. Its operations in Shanghai are conducted at Hongqiao International Airport and Pudong International Airport. On March 16, 2010, it moved its operations at Hongqiao International Airport to the terminal two of Hongqiao International Airport. It operates its flights through three hubs located in eastern, northwestern and southwestern China, namely Shanghai, Xi��n and Kunming, respectively.

Cargo and Mail Operations

The Company�� cargo and mail business utilizes the same route network used by its passenger airline business. It carries cargo and mail on its freight aircraft, as well as in available cargo space on its passenger aircraft. Its cargo and mail routes are international routes. As of December 31, 2010, it had seven MD-11F, four B777F and two B757-200F freight aircraft under operating leases for cargo and mail operations. It also has three Airbus A300-600R aircraft, as well as two Boeing 747-400ER freighters for its cargo operations.

The Company competes with Air China Limited, China Southern Airlines Company Limited, Hong Kong Dragon Airlines Limited, Cathay Pacific Airways, Thai Airways International, Singapore Airlines, Delta Air Lines, United Airlines, American Airlines, Air Canada, Delta, Alitalia, Air France-KLM Group, Asiana Airlines, Korean Air, Virgin Atlantic Airways, British Airways, Lufthansa German Airlines, Aeroflot and Qantas Airways.

Advisors' Opinion:

• [By Belinda Cao]

  The Bloomberg China-US Equity Index (CH55BN) of the most-traded Chinese companies in the U.S. slumped 3.4 percent last week to a seven-month low of 89.04. The gauge traded at 13.5 times estimated earnings, 3.6 percent below the S&P�� valuation, data compiled by Bloomberg show. China Southern Airlines Co. (ZNH) and China Eastern Airlines Corp. (CEA) lost more than 6 percent April 5, while Home Inns & Hotels Management Inc. (HMIN) tumbled 16 percent in the week.

5 Best Medical Stocks To Buy Right Now

Demographics tell us that an aging population will be increasingly reliant on medical care of all types. The best way to play a broad demographic trend is to invest in a basket of related stocks that will benefit from the trend. The aging population should revitalize pharmaceutical, biotech and medical technology companies over the coming years.

The H&Q Healthcare Investors (HQH) closed-end fund invests in health care and medical technology firms. In addition, the fund has the ability to invest in private equity firms and in foreign securities, although it currently holds more than 90% of its assets in U.S. listed companies. Current top holdings include Gilead Sciences, Regeneron Pharmaceuticals, Amgen and Biogen Idec.

H&Q Healthcare currently trades at $26.51 with a net asset value of $27.81 giving the fund a discount of ��.67%. Its 52-week average discount has been -0.47%. The fund has shown volatility in its discount with a one-year range between a premium of 8.82% and a discount of ��.69%.

Top 10 Canadian Companies To Watch In Right Now: Koninklijke Philips NV (PHIA)

Koninklijke Philips NV, formerly Koninklijke Philips Electronics NV, is the Netherlands-based parent company of the Philips Group (Philips). The Company operates within three main business sectors, such as Healthcare, Consumer Lifestyle, and Lighting, as well as through the Innovation, Group & Services (IG&S) sector. The Healthcare sector offers both personal care and professional products, such as computer tomography equipment, radiography equipment and refurbished systems. Consumer Lifestyle sector offers a range of sound, vision, personal devices and household products, such as television, headphones, kitchen appliances, shavers and digital cameras, among others. Lighting sector offers lighting products, such as professional lamps, light-emitting diodes (LED), ballasts and luminaires, among others. The IG&S segment provides the operating sectors with support through shared service centers. It also includes projects which are not part of the operating sectors. Advisors' Opinion:

• [By Corinne Gretler]

  European stocks rose for a fourth day, extending a seven-week high, as companies from UBS AG to Royal Philips (PHIA) Electronics NV reported increased profit.

5 Best Medical Stocks To Buy Right Now: Intrexon Corp (XON)

Intrexon Corporation, incorporated on April 19, 2004, is engaged in the business of synthetic biology. Using the Company�� suite of complementary technologies, it design, build and regulate gene programs, or sequences of deoxyribonucleic acid (DNA) that control cellular function, and cellular systems, or activities that take place within a cell and the interaction of those systems in the greater cellular environment, to enable the development of new and improved products and manufacturing processes across a variety of end markets, including healthcare, food, energy and environmental sciences. Its technologies include the UltraVector gene design and fabrication platform; Cell Systems Informatics; LEAP-cell identification and selection, and mAbLogix-antibody discovery.

The Company�� LEAP technology facilitates the automated identification of an individual cell with the highest levels of expression, quality and potency from a population of over 100,000 cells. Its mAbLogix platform complements UltraVector with a library of human antibodies that exceeds 500 million. By immortalizing human tonsils, which consists of lymphatic tissue containing B-cells, its mAbLogix platform creates a B-cell library that can generate antibodies against an almost infinite number of new antigens.

The UltraVector gene design and fabrication platform

The Company�� gene program design platform, which it refer to as UltraVector, is an integrated suite of tools comprising advanced DNA construction technology and components, cellular and protein engineering tools, computational models and statistical methods which facilitate the rapid design, build and testing of complex systems. The UltraVector platform allows the Company to translate gene programs into standard components that can be designed, manufactured and tested in an automated format. This technology enables it to engineer at the cellular level from biological sources.

UltraVector DNA design is computer-automated and ! utilizes a set of defined construction rules to assemble components that are stored in its DNA library. In addition to the number of gene components in its UltraVector library, it is designing and creating enzymatic and regulatory components that provide control over genome integration and gene regulation. Its RheoSwitch Therapeutic System is a three-component transcriptional regulator that provides inducible gene expression. The RheoSwitch Therapeutic System provides the ability to not only express proteins/enzymes of interest, but also the ability to control the level and timing of expression to achieve a biological outcome. Other ongoing programs include its Attsite recombinases, which mediate predictable gene exchange into host cells thereby eliminating many of the difficulties seen with traditional gene insertion.

Cell Systems Informatics

The Company�� Cell systems informatics permits design, as well as testing and learning about new gene targets or product pathways. Its bioinformatics software and database systems for mapping cellular pathways when combined with its genome-scale modeling and experimental data, including, gene expression profiling and protein engineering, enable the Company to optimize selection and development of gene programs and cellular systems for its collaborators. Its computational modeling and simulation platform enables the development of predictive computer models of organisms, from microbes to humans. This platform builds virtual cells from their basic molecular components, and can simulate the activity of the cell�� complete reaction network.

The Company is designing proteins with post-translational modifications. It is also working to develop enzyme inhibitors and fusion proteins for a variety of applications in human and animal therapeutics. Its protein engineering may utilize one or more of its technologies to obtain catalysis activitiesits component library, the generation of component variants sequence, evolutionary analy! sis and s! tructure-based sequence alignment, computer-aided drug discovery, de novo, or synthesized or generated, and comparative protein modeling, molecular dynamics simulation and free energy analysis, antibody design and humanization, antigenicity prediction, protein pharmacokinetics optimization, and/or in silico support of enzyme engineeringand quantitative structure-function relationships with machine learning algorithms to optimize, facilitate and prioritize protein variant libraries for the advancement of its collaborators.

LEAP-cell identification and selection

The Company�� Laser-Enabled Analysis and Processing technology (LEAP), is an instrument that merges semiconductor manufacturing technologies for cell processing applications to provide high levels of control and scale to cell purification and stem cell culture management. The LEAP platform can identify and purify cells of interest from large libraries of cells created by its UltraVector and bioinformatics technologies using a laser-based purification process, thereby providing a mechanism of testing the degree of protein expression in genetically modified cells, as well as means to learn from the genetic building process.

mAbLogix- antibody discovery

The Company�� mAbLogix antibody discovery platform, or mAbLogix platform, enables production of B-cell libraries for discovery of antibodies. The mAbLogix platform permits antigen targeting using fully human monoclonal and polyclonal antibodies. Its mAbLogix antibody discovery process consists of two major activities: the build of human B-cell libraries expressing a large number of antibodies, and the testing of these libraries based on an analysis of B-cells that express antibodies in response to a chosen antigen.

The Company competes with AbD SeroTec, Alexion Pharmaceuticals, Inc., XOMA Corporation, Genmab US, Inc., MorphoSys AG, NovImmune SA, Societe Des Systemes Biologiques, Adimab, LLC, ProMab Biotechnologies, Inc., Abpro, Inc.,! AIIM The! rapeutics and Open Monoclonal Technology, Inc.

Advisors' Opinion:

• [By Ben Levisohn]

  Overvalued companies include MWI Veterinary (MWIV) and�Stericycle (SRCL), while companies with attractive valuations include Cardinal Health (CAH), Selected Medical (SEM). He’s not a fan of Intrexon (XON) but calls�Aratana (PETX) a “hidden gem.”

• [By Jon C. Ogg]

  Intrexon Corp. (NYSE: XON) was started as Buy at Mizuho Securities, started as Equal Weight at Barclays and started as Overweight at J.P. Morgan.

  Nokia Corp. (NYSE: NOK) was raised to Hold from Sell at Deutsche Bank, raised to Neutral from Underperform at Credit Suisse and
  Canaccord Genuity raised its price target to $5.50 from $3.30.

5 Best Medical Stocks To Buy Right Now: Protalix Biotherapeutics Inc (PLX)

Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. Using its ProCellEx system, the Company is developing a pipeline of biosimilar or generic versions of recombinant therapeutic proteins based on its plant cell-based expression technology, which focuses pharmaceutical markets and that rely upon known biological mechanisms of action. ProCellEx protein expression system consists of a set of technologies and capabilities for the development of recombinant proteins, including advanced genetic engineering technology and plant cell-based protein expression methods. Its ProCellEx protein expression system is built on flexible custom-designed bioreactors made of polyethylene and optimized for the development of complex proteins in plant cell cultures. In June 2010, it had completed the preliminary phase I clinical trial of PRX-105.

Taliglucerase Alfa

Taliglucerase alfa is a plant cell expressed recombinant glucocerebrosidase enzyme (GCD) for the treatment of Gaucher disease. The Company has commenced pre-clinical studies of an oral form of taliglucerase alfa. Its oral taliglucerase alfa is a plant cell expressed form of GCD that is naturally encapsulated within carrot cells genetically engineered to express the GCD enzyme. Pre-clinical studies of oral taliglucerase alfa demonstrate the stability of the enzyme in the cell and the capacity of the cell�� cellulose wall to protect the enzyme against degradation in the digestive tract in an in-vitro model of the stomach and intestines. Additionally, rats fed with lyophilized carrot cells expressing GCD have accumulated the active enzyme in the target organs; the spleen and liver. As of December 31, 2010, the Company had completed Phase III Clinical Trial.

PRX-102

The Company is developing PRX-102, its plant cell expressed modified version of the recombinant ! alpha-GAL-A protein, a therapeutic enzyme for the treatment of Fabry disease. Fabry disease is a rare, hereditary, genetic lysosomal storage disorder in humans caused by an X-lined deficiency of the alpha-GAL-A enzyme. The Company is in the animal evaluation testing phase of the development of PRX-102, which tests are based on a mouse model for Fabry disease.

Acetylcholinesterase

Protalix Ltd. is a wholly owned subsidiary of the Company is licensed the rights to certain technology under a research and license agreement with Yissum Research and Development Company (Yissum) and the Boyce Thompson Institute, Inc. Pursuant to the agreement, the Company is developing PRX-105, a plant cell-based acetylcholinesterase (AChE) and its molecular variants for the use in several therapeutic and prophylactic indications, as well as in a biodefense program and an organophosphate-based pesticide treatment program.

As of December 31, 2010, its in-vitro experiments of PRX-105 have shown that the acetylcholinesterase enzyme in its ProCellEx protein expression system demonstrates biological activity on biochemical and cellular levels. In addition, early animal studies demonstrated that the acetylcholinesterase expressed in its ProCellEx protein expression system was able to treat animals exposed to the nerve gas agent analogues, both when injected with its acetylcholinesterase product candidate immediately before exposure or when injected after exposure. In March 2010, it initiated a preliminary phase I clinical trial of PRX-105, which the Company completed in June 2010.

pr-antiTNF

pr-antiTNF is a candidate for the treatment of certain autoimmune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing, spondylitis, psoriatic arthritis and plaque psoriasis. The Company has designed the antiTNF as pr-antiTNF. pr-antiTNF is a plant cell-expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR), f! used to t! he Fc component of a human antibody domain. pr-antiTNF has an identical amino acid sequence to Enbrel and its in-vitro and preclinical animal studies have demonstrated that pr-antiTNF exhibits similar activity to Enbrel. Specifically, pr-antiTNF binds TNF thereby inhibiting it from binding to cellular surface TNF receptors and protects L929 cells from TNF-induced apoptosis in a dose-dependent manner.

The Company competes with Genzyme, Actelion, Crucell N.V., Biolex, Inc., Chlorogen, Inc., Greenovation Biotech GmbH, Symbiosys, Novartis AG/Sandoz Pharmaceuticals, BioGeneriX AG, Stada Arzneimittel AG, BioPartners GmbH and Teva.

Advisors' Opinion:

• [By Maxx Chatsko]

  Industrial biotech isn't the only industry headed to Brazil. Protalix (NYSEMKT: PLX  ) entered into a technology transfer agreement with Brazil's Ministry of Health last week that will pay the company $280 million. The deal is big news for Protalix's first product, Elelyso/Uplyso, which was developed with partner Pfizer (NYSE: PFE  ) . The treatment is approved as an enzyme replacement therapy, or ERT, for adults with type 1 Gaucher disease, and it marks a huge step forward for the future of biomanufacturing. In the following video, Fool contributor Maxx Chatsko explains what this means for the product's commercialization and the adoption of Protalix's novel plant cell-based expression system for therapeutic proteins.

• [By Keith Speights]

  Other investors might wish that Pfizer would use some of its cash to acquire a few smaller companies. Protalix BioTherapeutics (NYSEMKT: PLX  ) has been mentioned as one possible candidate. The two companies already partner together on Gaucher disease drug Elelyso. In February, Protalix spurred rumors that Pfizer could be interested in buying the company after it announced that it had engaged Citigroup to pursue a "broad array of strategic alternatives."

5 Best Medical Stocks To Buy Right Now: Integra LifeSciences Holdings Corp (IART)

Integra LifeSciences Holdings Corporation (Integra), incorporated on June 19, 1989, is an integrated medical technology company. Integra offers solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. The Company has developed numerous product lines for applications ranging from burn and deep tissue wounds to regeneration of dura mater in the brain and repair of nerve and tendon. It operates in five business segments: U.S. Neurosurgery, U.S. Extremities, U.S. Instruments, U.S. Spine and Other, and International. The International segment sells similar products to Europe, Middle East and Africa, and Central/South America, Asia-Pacific and Canada. On April 29, 2013, the Company launched the Integra Compact Cranial Closure System, which provides titanium implants for non-loadbearing (non-facial) operative cranial neurosurgical procedures. On April 30, 2013, it released its Hollywood VI intervertebral body fusion device (IBD) system. In January 2014, Integra LifeSciences Holdings Corp completed the acquisition of DuraSeal product lines from Covidien. In January 2014, Covidien PLC completed the sale of its Confluent Surgical product line to Integra LifeSciences Corporation.

U.S. Neurosurgery

The Company�� U.S. Neurosurgery sales organization sells a full line of products for neurosurgery and neuro critical care. It has products for each step of a cranial procedure and the care of the patient after surgery. Its key products include dural repair products, cerebral spinal fluid (CSF) management devices, tissue ablation equipment, intracranial monitoring equipment and cranial stabilization equipment. The Company sells equipment used in the neurosurgery operating room and neurosurgery intensive care unit (NICU).

U.S. Extremities

Extremity reconstruction includes the repair of soft tissue and the orthopedic reconstruction of bone in the foot, ankle and leg below the knee (Lower Extremity), and the hand, ! wrist, elbow and shoulder (Upper Extremity). Its key products include bone and joint fixation devices, implants and instruments for osteoarthritis, rheumatoid arthritis, wrist arthroplasty, carpel tunnel syndrome, and cubital tunnel syndrome. Other key products include its regenerative medicine devices for the treatment of acute and chronic wounds, peripheral nerve repair and protection and tendon repair, and bone graft substitutes.

U.S. Instruments

Integra�� U.S. Instruments business is a surgical instrument suppliers in the United States. Its portfolio includes over 60,000 instrument patterns and surgical products sold a range of users, including hospitals, surgery centers, and physician, dental and veterinary offices. In addition to selling hand-held instruments, it sells surgical headlight systems and table-mounted retractors. The Company�� brands include Jarit, Miltex, Padgett, Ruggles, Luxtec and Omni-Tract.

U.S. Spine and Other

Integra�� U.S. Spine and Other segment offer spinal fusion technologies that surgeons use along the full length of the spine, as well as a range of related orthobiologics. During the year ended December 31, 2012, its Spine business launched multiple new implants into the integrated interbody fusion device market and the deformity market. Its key spinal hardware products include integrated interbody fusion devices, minimally invasive solutions, and deformity correction. It markets and sells a complete line of orthobiologics, including demineralized bone products, collagen ceramic matrices and pure synthetic bone grafting solutions, to neurosurgeons, and spine, orthopedic, trauma, and foot and ankle surgeons. Integra sells its products through specialty distributors focused on its spine and orthopedic surgeon customers, as well as through some direct sales representatives. This segment also includes private-label sales of a set of its regenerative medicine technologies. Its customers are other large medical technology! companie! s that sell to end markets primarily in orthopedics and wound care.

The Company competes with Johnson & Johnson, Synthes, Inc., Stryker Corporation, Tornier, Inc., Wright Medical Group, Inc., Zimmer, Inc., Small Bone Innovations, Inc., Medtronic, Inc., Globus Medical Inc., NuVasive, Inc., Orthofix, Alphatec Spine, Inc., B. Braun Medical Inc., CareFusion and Symmetry Medical.

Advisors' Opinion:

• [By Ben Levisohn]

  Shares of Align have surged 24% to $57 at 12:37 p.m. Sirona Dental Systems (SIRO) has risen 0.8% to $69.61, Dentsply International (XRAY) is up 0.1% at $45.44, Integra Lifesciences (IART) has� gained 0.4% to $44.23 and Danaher (DHR) has fallen 0.3% to $72.13.

Top 10 Warren Buffett Companies To Watch In Right Now

LONDON -- One of Warren Buffett's famous investing sayings is "be fearful when others are greedy and greedy only when others are fearful" -- or, in other words, sell when others are buying and buy when they're selling.

But we might expect Foolish investors to know that, and looking at what Fools have been buying recently might well provide us with some ideas for good investments.

So, in this series of articles, we're going to look at what customers of The Motley Fool ShareDealing Service have been buying in the past week or so, and what might have made them decide to do so.

Healthy yield
At the start of last week,�SSE� (LSE: SSE  ) -- the utility company formerly known as Scottish & Southern Energy -- released its preliminary results for the year to the end of March 2013. In them, it revealed that its pre-tax profits had risen 5.6% year on year, to 拢1.4 billion, on the back of a 21% increase in U.K. household gas consumption (a result of the extended cold winter weather) and a 5% rise in electricity usage. And the increases were despite a disappointing near-1% fall in the number of SSE's energy customer accounts, now down to 9.47 million.

5 Best Telecom Stocks To Invest In 2015: Cosi Inc.(COSI)

Cosi, Inc. owns, operates, and franchises premium convenience dining restaurants. It offers squagels, sandwiches, hearth-baked quiches, oatmeal, salads, soups, appetizers, melts, flatbread pizzas, S?mores, fruit parfaits, wraps, and other desserts; coffees and other espresso-based beverages, seasonal fruit smoothies and specialty drinks, soft drinks, and flavored teas, as well as bottled beverages, such as still and sparkling waters. The company also sells alcoholic beverages comprising beer and wine. Its restaurants also offers catering service for the breakfast and lunch day parts, including breakfast baskets, lunch buffets, and dessert platters. As of August 26, 2011, it had 80 company-owned and 58 franchise restaurants in 17 states in the United States, the District of Columbia, and the United Arab Emirates. Cosi, Inc. was founded in 1994 and is based in Deerfield, Illinois.

Advisors' Opinion:

• [By John Udovich]

  At the end of last week, small cap sandwich stock Potbelly Corp (NASDAQ: PBPB) had a delicious surge of 120% for its IPO���meaning its probably a good idea to see whether its still worth getting in on the action plus take a look at the performance of peers�Cosi Inc (NASDAQ: COSI), Panera Bread Co (NASDAQ: PNRA) and Einstein Noah Restaurant Group, Inc (NASDAQ: BAGL) as Subway remains private. I should mention that competing with Subway in the sandwich business is a tall order as they have 40,229 restaurants in 102 countries and territories as of early September���making them the�largest single-brand restaurant chain and the largest restaurant operator globally. However, Potbelly Corp and its peers Cosi Inc, Panera Bread Co and Einstein Noah Restaurant Group aren�� slugging it out directly with Subway.

• [By James Brumley]

  But Sbarro is hardly the only restaurant struggling to make ends meet right now. Indeed, there are several more that may be following in the pizza chain’s bankruptcy footsteps. In no particular order, here are five more restaurants that may be fiscally insolvent in the foreseeable future.

  Cosi (COSI)

  The sandwiches may be delicious, but the menu Cosi Inc. (COSI) offers at its 136 restaurants is increasingly irrelevant, either for price (the average ticket size is about $8.81), convenience, or both.

• [By Anna Prior]

  Cosi Inc.(COSI) named Yum Brands Inc.(YUM) veteran Scott Carlock as the chief financial officer of the struggling sandwich chain.

  Cloud-based software provider E2open Inc.'s(EOPN) loss widened in its fiscal first quarter as operating expenses continued to rise.

• [By Peter Graham]

  The Q1 2014 Potbelly Corp (NASDAQ: PBPB) earnings report is scheduled for after the market closes on Tuesday, May 6th, with investors and traders alike who follow either the sandwich restaurant chain stock (which debuted last October and is down some 44% for retail investors)�or who are into potential small cap peers like Cosi Inc (NASDAQ: COSI), Einstein Noah Restaurant Group, Inc (NASDAQ: BAGL) and Panera Bread Co (NASDAQ: PNRA) should be paying attention. Aside from the Potbelly Corp earnings report, it should be said that the Q1 2014 Panera Bread Co earnings report was last Tuesday while the�Q1 2014 Einstein Noah Restaurant Group, Inc earnings report came last Thursday and the the Q1 2014 Cosi Inc�earnings report is likely scheduled for Monday, May 12. However, Potbelly Corp has attracted a bit of attention for its potential growth trajectory as well as its�vision to be the ��eighborhood Sandwich Shop.��/p>

Top 10 Warren Buffett Companies To Watch In Right Now: Sanmina-SCI Corporation(SANM)

Sanmina-SCI Corporation provides integrated electronics manufacturing services worldwide. It offers product design and engineering services, including initial development, detailed design, prototyping, validation, preproduction, and manufacturing design; volume manufacturing of complete systems, components, and subassemblies; final system assembly and testing services; direct order fulfillment and logistics services; and after-market product service and support services. The company also manufactures various system components and subassemblies consisting of printed circuit boards, printed circuit board assemblies, backplanes and backplane assemblies, enclosures, cable assemblies, precision machine components, optical components and modules, and memory modules. It provides its services to original equipment manufacturers primarily in the communication, enterprise computing and storage, multimedia, industrial and semiconductor capital equipment, defense and aerospace, medica l, clean technology, and automotive industries. The company was founded in 1980 and is based in San Jose, California.

Advisors' Opinion:

• [By Eric Volkman]

  After being in the red last quarter, Sanmina's (NASDAQ: SANM  ) bottom line has swung into positive territory. In the company's Q2 results, net sales amounted to $1.43 billion, down from the $1.46 billion in the same period the previous year. The bottom line came in at $21.2 million ($0.25 per diluted share) from Q2 2012's net loss of $1.4 million ($0.02) according to GAAP standards.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Sanmina (Nasdaq: SANM  ) , whose recent revenue and earnings are plotted below.

• [By Evan Niu, CFA]

  What: Shares of Sanmina (NASDAQ: SANM  ) have popped today by as much as 16% after the company reported earnings.

  So what: Revenue in the fiscal second quarter was $1.43 billion, and non-GAAP earnings per share came in at $0.30. That top-line result was in line with consensus estimates while the bottom-line was a beat relative to�estimates. CEO Jure Sola said the company continues to face a "soft market environment" but that Sanmina continues to invest in technology and services, with new program ramps on the horizon.

• [By John Kell var popups = dojo.query(".socialByline .popC"); popups.forEach(func]

  Shares of Sanmina Corp.(SANM) jumped in after-hours trading Tuesday as the electronics manufacturer posted better-than-expected results for the fiscal second quarter. Sanmina also issued rosy outlook targets for the current quarter, pushing shares up 9.5% to $20 premarket.

Top 10 Warren Buffett Companies To Watch In Right Now: Miller Energy Resources Inc. (MILL)

Miller Energy Resources, Inc. engages in the exploration, production, and drilling of oil and natural gas resources in the United States. It primarily holds interests in approximately 600,000 lease acres located in the Cook Inlet area of Alaska; and 54,500 acres of lease holdings located in the Appalachian Basin, Tennessee. The company was formerly known as Miller Petroleum, Inc. and changed its name to Miller Energy Resources, Inc. on April 12, 2011. Miller Energy Resources, Inc. is headquartered in Huntsville, Tennessee.

Advisors' Opinion:

• [By James E. Brumley]

  To be fair, it might be years before PROP really starts to worry the likes of Denbury Resources and Halliburton Company. That doesn't dampen the size of the opportunity for Propell Technologies Group Inc. in the meantime, though. In fact, considering major oil players like Miller Energy Resources Inc. (NYSE:MILL), LUKOIL (OTCMKTS:LUKOY), and ConocoPhillips (NYSE:COP) have already utilized this plasma-boring service and liked the results, PROP may grow into a real threat to the sol-called "majors" before anyone realizes it's happening, ultimately spurring an acquisition of the company. When the provisionally-patented technology is this good, we can't rule out any rewarding outcome for the stock.

Top 10 Warren Buffett Companies To Watch In Right Now: First Financial Bankshares Inc.(FFIN)

First Financial Bankshares, Inc., through its subsidiaries, provides commercial banking products and services primarily in Texas. It offers commercial banking services, which include accepting and holding checking, savings, and time deposits, as well as automated teller machines, drive-in and night deposit services, safe deposit facilities, remote deposit capture services, Internet banking, transmitting funds, and other commercial banking services. The company also provides commercial, financial, agricultural, real estate construction, real estate mortgage, and consumer loans to businesses, professionals, individuals, and farm and ranch operations. In addition, it involves in the administration of various types of retirement and employee benefit accounts, which include 401(k) profit sharing plans and IRAs; and offers personal trust services that comprise the administration of estates, testamentary trusts, revocable and irrevocable trusts, and agency accounts. Further, the company offers securities brokerage services. As of December 31, 2009, it operated 48 financial centers in Texas, including 10 locations in Abilene, 2 locations in Cleburne, 3 locations in Stephenville, 3 locations in Granbury, 2 locations in San Angelo, and 3 locations in Weatherford, as well as 1 location each in Mineral Wells, Hereford, Sweetwater, Eastland, Ranger, Rising Star, Southlake, Aledo, Willow Park, Brock, Alvarado, Burleson, Keller, Trophy Club, Boyd, Bridgeport, Decatur, Roby, Trent, Merkel, Clyde, Moran, Albany, Midlothian, and Glen Rose. The company was founded in 1956 and is based in Abilene, Texas.

Advisors' Opinion:

• [By John Udovich]

  Texas has set another record for job creation�with small cap Texas banking stock like Texas Capital Bancshares (NASDAQ: TCBI), ViewPoint Financial Group (NASDAQ: VPFG) and First Financial Bankshares (NASDAQ: FFIN) naturally being well positioned to take advantage of the Texas economic miracle (see my previous article: Texas is Booming and So Are These Texas Stocks (EE, TPL & ATO)). I should�add that I wrote about�these Texas banking stocks back in late 2012�(see: Don�� Mess With Texas Banking Stocks TCBI, VPFG & FFIN) and the Texas Workforce Commission has just�reported that the Texas economy added 36,400 jobs in September while over the past 12 months, employers added 413,700 jobs ��the most ever recorded by the state. Moreover, several companies surveyed by the Dallas Fed responded by saying�they are seeing labor market tightness�while companies are saying they are experiencing upward wage pressures�and�staffing�firms�note that�candidates are often receiving multiple offers.

• [By David Hanson and Matt Koppenheffer]

  In the following video, Motley Fool financial analysts David Hanson and Matt Koppenheffer discuss two stocks from the financial sector that they're watching today. David tells us why he's got his eye on�JPMorgan� (NYSE: JPM  ) and the trials and tribulations of CEO Jamie Dimon and what he'll be looking for at the company's annual meeting in two weeks. Matt Koppenheffer discusses the smaller-cap�First Financial Bankshares (NASDAQ: FFIN  ) �and why if Warren Buffett only had $1 million to invest, this might be one of the first places he'd look.

Top 10 Warren Buffett Companies To Watch In Right Now: ARC Document Solutions Inc (ARC)

ARC Document Solutions, Inc., formerly American Reprographics Company, provides specialized document solutions to businesses of all types, with a focus on the non-residential segment of the architecture, engineering and construction (AEC) industry. The Company offers reprographic services, as well as managed print services, digital color printing, and document management technology products and services. It also has operations in Canada, China, India and the United Kingdom. It is a document solutions company serving the AEC industry that provides document management services through a combination of local service facilities in more than 40 states, 12 digital color service centers, online channels, including Web-based applications, and software. The Company conducts its operations through a wholly owned subsidiary, American Reprographics Company, L.L.C. and its subsidiaries.

The Company offers three general categories of service: Reprographics Services, Facilities Management, and Equipment and Supplies. Reprographics Services sales include operational activities, such as document management services, document logistics, large- and small-format print-on-demand services in color and black and white, and digital document management services. Facilities Management sales are primarily composed of onsite services, where it provides document production equipment, technology solutions and sometimes staff to its customers in their offices. These services include both traditional reprographics services focused on large-format printing, as well as managed print services (MPS). Under an MPS contract, it supplies, maintains and manages a customer�� entire print networks, including office printing equipment, on an outsourced basis. Equipment and Supplies sales involve the resale of printing and imaging equipment and supplies from a variety of suppliers.

As of December 31, 2011, the Company operated 220 reprographics service centers, of which 199 were in the United States, seven were in ! Canada, 11 were in China, two were in India and one in London, England. It also occupied a technology center in Silicon Valley, California, a software programming facility in Kolkata, India, as well as other facilities, including its offices located in Walnut Creek, California. The Company�� products and services are available from any of ARC�� 220 service centers worldwide. The Company supplies reprographics services to project architects, engineers, general contractors and others. In addition to the AEC industry, ARS also provides document management and printing services to the retail, aerospace, technology, entertainment, and healthcare industries, among others.

The Company competes with Oce, Xerox, Canon, Konica Minolta, Ricoh and Sharp.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on ARC Document Solutions (NYSE: ARC  ) , whose recent revenue and earnings are plotted below.

Top 10 Warren Buffett Companies To Watch In Right Now: Deutsche Bank AG(DB)

Deutsche Bank Aktiengesellschaft provides investment, financial, and related products and services. The company?s Corporate and Investment Bank division engages in the origination, sale, structuring, and trading of bonds, equities and equity-linked products, exchange-traded and over-the-counter derivatives, foreign exchange, money market instruments, securitized instruments, and commodities to sovereign countries and multinational organizations; and medium-sized companies and multinational corporations. It also offers mergers and acquisitions advisory, corporate finance, and transaction banking, as well as trade finance, cash management, and trust and securities services for financial institutions and other companies. The company?s Private Clients and Asset Management division provides mutual funds and alternative investment products; manages real estate and infrastructure investments and private equity funds; offers advisory and portfolio management services to insurance companies; and provides investment solutions to institutional customers, high net worth individuals, and families. This division also offers a range of banking products and services, including current accounts, deposits and loans, and investment management and pension products to private and self-employed individuals, and small to medium-sized businesses. Its Corporate Investments division?s principal investment activities comprise private equity and venture capital investments, corporate real estate investments, a minority stake in Deutsche Postbank AG, credit exposures, and other non-strategic investments. As of December 31, 2010, the company operated 3,083 branches in approximately 74 countries worldwide, including 2,087 in Germany. Deutsche Bank Aktiengesellschaft was founded in 1870 and is headquartered in Frankfurt am Main, Germany.

Advisors' Opinion:

• [By Jessica Alling]

  3. Market share
  Citi has cut Deutsche Bank's (NYSE: DB  ) lead in currency trading down to 0.28% as it made gains in the emerging markets. Citi currently holds 14.9% of the market for currency trades, with 15.68% in emerging markets. Asia, where Citi is well positioned, accounted for a larger cut of the trading, jumping from 21% to 26%. The currency trading market accounted for $225 trillion in turnover, making it a huge win for Citi to march toward the top spot.

Top 10 Warren Buffett Companies To Watch In Right Now: Astellas Pharma Inc (ALPMY.PK)

Astellas Pharma Inc. is a Japan-based company mainly engaged in the pharmaceutical business. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea and Taiwan, through its subsidiaries. Its main products include immunosuppressive drug Prograf, overactive bladder agent Vesicare, Protopic ointment for atopic dermatitis, Harnal for prostatic and urethral smooth muscle, and antimycotic agent Funguard, among others. It also provides pharmaceutical products for gastritis, chronic hepatitis C, irritable bowel syndrome, osteoporosis, hypertension, schizophrenia, rheumatoid arthritis, agrypnia, atopic dermatitis and other diseases. Advisors' Opinion:

• [By Henry Kawabe]

  Seattle Genetic is currently collaborating on 22 different ADC drug trials in various stages of testing with twelve different pharmaceutical companies, including nine with Genentech (RHHBY.OB), two with AbbVie (ABBV), two with Agensys (ALPMY.PK), and one with Pfizer (PFE). To date, these ADC collaborations have generated more than $225 million for Seattle Genetics and have the potential to generate more than $3.5 billion in milestone payments plus royalties.